Nosuffern (Ibuprofen, Paracetamol)

Ibuprofen inhibits cyclooxygenase enzymes, reducing prostaglandin production at sites of inflammation, which lessens pain and swelling. Paracetamol acts mainly in the central nervous system, blocking COX activity and influencing serotonergic pathways to lower pain perception and reset the body’s temperature set‑point.

The appropriate dose of Nosuffern is determined by a qualified prescriber or according to the product label. Dosage depends on factors such as age, weight, the severity of symptoms, and any underlying health conditions. Always follow the specific instructions provided by your healthcare professional.

Safety in pregnancy and lactation has not been definitively established for the ibuprofen/paracetamol combination. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Nosuffern.

To request Nosuffern, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Compared with single‑ingredient ibuprofen or paracetamol tablets, Nosuffern offers a dual mechanism that can provide broader pain control and antipyretic effect at lower individual doses of each component. This may reduce the need for higher doses of a single agent, but the safety profile must still be considered, especially regarding gastrointestinal and hepatic risks.

Nosuffern should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Nosuffern is taken orally with a full glass of water. It can be taken with or without food, although taking it with food may lessen occasional stomach discomfort. Swallow the tablet whole; do not crush, chew, or split unless directed by a healthcare professional.

Serious risks include gastrointestinal bleeding, severe skin reactions such as Stevens‑Johnson syndrome, liver injury, renal impairment, and anaphylactic reactions. Prompt medical attention is required if you notice symptoms like black stools, unexplained jaundice, swelling of the face or throat, or a widespread rash.

Nosuffern should be avoided by individuals with known hypersensitivity to ibuprofen, paracetamol, or any formulation excipients. It is also contraindicated in patients with active peptic ulcer disease, severe liver or kidney impairment, and in those who are currently taking other NSAIDs or anticoagulants without medical supervision.